Recently, mutations in the presynaptic, Na-dependent, high-affinity choline transporter-1 (CHT) encoded by the SLC5A7 gene have been identified as a rare cause of CMS [20]. This evidence concerns the gene SLC5A7 and congenital myasthenic syndrome.